Gen9 Inks Synthetic DNA Supply Deal With Amyris | GenomeWeb

NEW YORK (GenomeWeb) – Gen9 has signed a deal to supply synthetic DNA to renewable products firm Amyris, the companies announced today.

Under the terms of the agreement, Gen9 will provide Amyris with multiple megabases of synthetic DNA content for use in its microbial engineering pipeline. Additional terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.